Introduction
Reduction in serum protein-bound iodine (PBI) levels in phenytoin-treated individuals was first reported by Oppenheimer, Fisher, Nelson & Jailer, (1961) . This phenomenon was apparent even in hypothyroid patients maintained on a constant exogenous dose of thyroid hormone thus indicating an extrathyroidal drug effect. Subsequent in vitro studies showed that phenytoin displaces thyroxine from thyroxine-binding globulin (Wolff, Standaert & Rail, 1961) and increases the dialysable fraction of thyroxine (Oppenheimer & Tavernetti 1962 ). More recent in vivo studies suggested that while total serum thyroxine is lowered, its non-protein bound (free) fraction remains unaltered during phenytoin therapy with resultant reduction in the physiologically important absolute free (.1. non protein-bound) hormone concentration (Chin & Schussler, 1968; Larsen, Atkinson, Weilman & Goldsmith, 1970 Burke, Shakespeare & Fraser, 1972; Black, Griffiths, Finucane & Hoffenberg, 1975) prompted this study on the effects of long term phentoin therapy on serum total and non protein-bound thyroxine and triiodothyronine. It was hoped that useful additional data might be obtained from estimation of urine losses of unconjugated thyroid hormones in normal and phenytoin-treated subjects.
Methods

Subjects
The following groups were studied: (a) Twenty (Black et al., 1975) .
Serum free fractions of thyroxine and triiodothyronine were determined by a modification of the Sephadex gel filtration technique described by Lee, Henry & Golub, (1964) . Serum and urine creatinine concentrations were measured by an Autoanalyser method.
Urine was screened for the presence of protein by dropwise addition of 25% sulfosalicylic acid (0.5 ml) to urine (5 ml) following prior acidification with dilute hydrochloric acid. Absence of turbidity indicated a protein content of less than 10 mg/100 ml.
Results
All subjects appeared euthyroid on clinical examination.
Serum total, percentage free fraction and absolute free concentrations of thyroxine and triiodothyronine in normal and phenytoin-treated subjects are shown in Figure 1 . Mean normal values (range in brackets) were respectively 94 ng/ml (73-120 ng/ml); 0.052% (0.044-0.062%) and 49 pg/ml (40-67 pg/ml) for thyroxine, and 1.48 ng/ml (1.08-2.17 ng/ml); 0.40% (0.29-0.50%) and 5.9 pg/ml (3.5-7.9 pg/ml) for triiodothyronine. A highly significant decrease in serum total thyroxine with a comparable increase in free thyroxine fraction is apparent in phenytointreated subjects. This resulted in an appreciable increase over normal in the concentration of serum free thyroxine. A similar but less striking pattern is seen in the case of triiodothyronine except that the slight increase in serum free triiodothyronine does not achieve statistical significance. Mean values for serum total thyroxine were two thirds of normal and six individual values were in the hypothyroid range for this laboratory. In the case of triiodothyronine mean values were 15% below normal and three values were in the hypothyroid range. It is noteworthy that all individual values for serum free thyroxine and triiodothyronine concentrations in phenytoin-treated subjects were within our normal range and clearly indicated the euthyroid status of these patients.
Daily urine losses of unconjugated thyroid hormones are presented in Figure 2 . Mean normal values (range in brackets) were 1.95 pg (0.85-3.08,ug) for thyroxine and 1.07,g (0.66-1.73 Mg) for triiodothyronine. The increased thyroxine losses in phenytoin-treated patients were highly significant (P<0.00 1) but triiodothyronine losses did not differ significantly from normal. Accuracy of urine collection was monitored by simultaneously determining creatinine clearance. In every case, this exceeded 80 ml/minute.
Discussion
Results in the present study are at variance with previous studies by Chin & Schussler (1968) and Larsen et al., (1970) which suggested that no significant competitive displacement of thyroid hormones from serum binding proteins occurs in vivo following the administration of phenytoin in therapeutic doses. Because free hormone fraction was apparently unchanged from normal, serum free hormone concentration was reportedly reduced in proportion to the depression in serum total hormone levels. However, the ultrafiltration method used by both groups of workers to measure free thyroxine fraction is methodologically suspect (Spaulding & Gregerman, 1972) . Furthermore, no adequate explanation was offered for the other findings of Larsen et al., (1970) that absolute thyroxine degradation rate, generally assumed to be a function of free hormone concentration, was unchanged, and that urine and faecal losses of radioactive hormone were increased in phenytoin-treated subjects. In a recent study, Hansen, Skovsted, Lavridsen, Kirkegaard & Siersbaek-Nielsen (1974) found significantly reduced serum total concentrations both of thyroxine and triiodothyronine in patients treated longterm with phenytoin. Free thyroxine index was reduced and basal serum levels of thyroid stimulating hormone were increased. This was interpreted as indicating that serum free thyroxine concentration is lowered in patients treated long--term with phenytoin. However, it is doubtful that the triiodothyronine resin test used by these workers to calculate a free thyroxine index is sufficiently sensitive to detect a phenytoininduced decrease in thyroxine binding from a normal of 99.95% to 99.9% as found in the present study. Furthermore, the authors were unable to explain the lack of an exaggerated thyroid-stimulating hormone response to administered thyrotropin releasing-hormone in their phenytoin-treated patients.
Urinary levels of unconjugated thyroid hormones, in the absence of proteinuria, should reflect serum concentrations of unbound (.1. filterable) thyroxine and triiodothyronine. Chan, Besser & Landon (1972) recorded a marked increase in urinary thyroxine in one individual following the institution of phenytoin therapy. A subsequent study (Chan, 1974) showed slight but insignificant increases in thyroxine excretion in a group of phenytoin-treated subjects. Chan's (1974) assay method for urine unconjugated thyroxine involved acidification and alcohol extraction of urine-steps which lead to artefactually high estimations (Black, Griffiths, Hoffenberg & Leatherdale, 1973) .
The present study suggests that therapeutic levels of phenytoin significantly displace thyroid hormones from binding proteins resulting in reduced serum total hormone, increased free fraction and resultant increased free hormone concentration. These effects are more marked with regard to thyroxine than to triiodothyronine and are reflected in the urinary losses of unconjugated hormones which result from glomerular filtration of serum free hormones. Despite these phenomena, serum free hormone concentrations which probably determine the thyroid status of the individual, remain in the euthyroid range, unlike serum total hormone concentrations which may overlap with values in the hypothyroid range.
